Fagron NV

OTCGREY:ARSUF USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.47 Billion
Market Cap Rank
#6317 Global
#3554 in USA
Share Price
$20.03
Change (1 day)
+0.00%
52-Week Range
$20.03 - $20.03
All Time High
$24.61
About

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmeris… Read more

Fagron NV (ARSUF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2023: 0.049x

Based on the latest financial reports, Fagron NV (ARSUF) has a cash flow conversion efficiency ratio of 0.049x as of June 2023.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($21.64 Million) by net assets ($440.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Fagron NV - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Fagron NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Fagron NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fagron NV ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Fagron NV (2013–2024)

The table below shows the annual cash flow conversion efficiency of Fagron NV from 2013 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $505.36 Million $109.89 Million 0.217x -18.41%
2023-12-31 $467.63 Million $124.63 Million 0.267x -0.50%
2022-12-31 $408.63 Million $109.46 Million 0.268x +11.17%
2021-12-31 $325.47 Million $78.42 Million 0.241x -33.17%
2020-12-31 $257.82 Million $92.95 Million 0.361x +15.13%
2019-12-31 $246.44 Million $77.17 Million 0.313x -10.38%
2018-12-31 $209.72 Million $73.28 Million 0.349x -23.32%
2017-12-31 $184.88 Million $84.25 Million 0.456x +3.20%
2016-12-31 $152.88 Million $67.50 Million 0.442x +139.01%
2015-12-31 $-64.77 Million $73.31 Million -1.132x -274.67%
2014-12-31 $189.87 Million $123.03 Million 0.648x +59.40%
2013-12-31 $155.17 Million $63.08 Million 0.407x --